BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37165440)

  • 1. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients.
    Huang Y; Zhou S; Luo Y; Zou J; Li Y; Chen S; Gao M; Huang K; Lian G
    Radiat Oncol; 2023 May; 18(1):79. PubMed ID: 37165440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
    Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning.
    Yuan Z; Shu Z; Peng J; Wang W; Hou J; Han L; Zheng G; Wei Y; Zhong J
    Abdom Radiol (NY); 2024 Jan; 49(1):117-130. PubMed ID: 37819438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
    Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
    J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study.
    Zhao B; Xia C; Xia T; Qiu Y; Zhu L; Cao B; Gao Y; Ge R; Cai W; Ding Z; Yu Q; Lu C; Tang T; Wang Y; Song Y; Long X; Ye J; Lu D; Ju S
    Int J Surg; 2024 Feb; 110(2):740-749. PubMed ID: 38085810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.
    Li K; Yao Q; Xiao J; Li M; Yang J; Hou W; Du M; Chen K; Qu Y; Li L; Li J; Wang X; Luo H; Yang J; Zhang Z; Chen W
    Cancer Imaging; 2020 Jan; 20(1):12. PubMed ID: 32000852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.
    Liang L; Ding Y; Yu Y; Liu K; Rao S; Ge Y; Zeng M
    BMC Med Imaging; 2021 Apr; 21(1):75. PubMed ID: 33902469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
    Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
    J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from
    Gao J; Bai Y; Miao F; Huang X; Schwaiger M; Rominger A; Li B; Zhu H; Lin X; Shi K
    Clin Radiol; 2023 Oct; 78(10):746-754. PubMed ID: 37487840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
    Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8
    Bian Y; Liu C; Li Q; Meng Y; Liu F; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Zhao Z; Wang L; Xu J; Shao C; Lu J
    J Magn Reson Imaging; 2022 Mar; 55(3):803-814. PubMed ID: 34355834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Tumor-Infiltrating CD20
    Li Q; Yu J; Zhang H; Meng Y; Liu YF; Jiang H; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Feng X; Lu J; Shao C; Bian Y
    Acad Radiol; 2022 Sep; 29(9):e167-e177. PubMed ID: 34922828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
    Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
    Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
    Shi Z; Ma C; Huang X; Cao D
    J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative evaluating early recurrence in resectable pancreatic ductal adenocarcinoma by using CT radiomics.
    Wang G; Lei W; Duan S; Cao A; Shi H
    Abdom Radiol (NY); 2024 Feb; 49(2):484-491. PubMed ID: 37955726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?
    Zambirinis CP; Midya A; Chakraborty J; Chou JF; Zheng J; McIntyre CA; Koszalka MA; Wang T; Do RK; Balachandran VP; Drebin JA; Kingham TP; D'Angelica MI; Allen PJ; Gönen M; Simpson AL; Jarnagin WR
    Ann Surg Oncol; 2022 Aug; 29(8):4962-4974. PubMed ID: 35366706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.
    Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q
    Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of radiomics features extracted from preoperative cross-sectional imaging of pancreatic ductal adenocarcinoma in detecting lymph node metastasis: a systemic review and meta-analysis.
    Mirza-Aghazadeh-Attari M; Madani SP; Shahbazian H; Ansari G; Mohseni A; Borhani A; Afyouni S; Kamel IR
    Abdom Radiol (NY); 2023 Aug; 48(8):2570-2584. PubMed ID: 37202642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.